In a CD68-associated pan-cancer analysis, CD68 was found to be highly expressed in many cancer types and associated with immune infiltration in tumor mutation burden (TMB), microsatellite instability (MSI), and TME, which may become a new immune checkpoint in future tumor immunotherapy42. This evidence concerns the gene CD68 and cancer.